Geron (GERN) Capital Expenditures (2010 - 2024)
Geron's (GERN) quarterly Capital Expenditures came in at -$141000.0 in Q4 2024, down 320.31% year-on-year from $64000.0 in Q1 2024, and down 168.45% quarter-over-quarter from $206000.0 in Q2 2024.
Geron (GERN) Capital Expenditures (2010 - 2024) Analysis & Trends
Geron has disclosed Capital Expenditures across 14 years of filings, most recently posting -$141000.0 for Q4 2024.
- Capital Expenditures for Q4 2024 came in at -$141000.0, down 320.31% year-over-year; the trailing twelve-month figure through Dec 2024 was $680000.0 (down 18.07% YoY), and the FY2024 annual result was $680000.0, down 18.07% from the prior year.
- Capital Expenditures came in at -$141000.0 for Q4 2024 at Geron, down from $206000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $615000.0 in Q1 2024 to a low of -$141000.0 in Q4 2024.
- The 5-year median for Capital Expenditures is $121500.0 (2021), against an average of $141611.1.
- Across the five-year window, Capital Expenditures surged 2250.0% in 2021 and plunged 320.31% in 2024, its largest moves.
- Geron's Capital Expenditures stood at $11000.0 in 2020, then jumped by 836.36% to $103000.0 in 2021, then soared by 35.92% to $140000.0 in 2022, then plunged by 54.29% to $64000.0 in 2023, then slumped by 320.31% to -$141000.0 in 2024.
- The last three Capital Expenditures figures came in at -$141000.0 (Q4 2024), $206000.0 (Q2 2024), and $615000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -63,220.27 |
| 10 | Geron | 729,618.77 | 729,618.77 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -141,000.00 |
| Dec 31, 2024 | -141,000.00 |
| Jun 30, 2024 | 206,000.00 |
| Jun 30, 2024 | 206,000.00 |
| Mar 31, 2024 | 615,000.00 |
| Mar 31, 2024 | 615,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Sep 30, 2023 | 192,000.00 |
| Sep 30, 2023 | 192,000.00 |
| Jun 30, 2023 | 202,000.00 |
| Jun 30, 2023 | 202,000.00 |
| Mar 31, 2023 | 372,000.00 |
| Mar 31, 2023 | 372,000.00 |
| Dec 31, 2022 | 140,000.00 |
| Dec 31, 2022 | 140,000.00 |
| Sep 30, 2022 | 171,000.00 |
| Sep 30, 2022 | 171,000.00 |
| Jun 30, 2022 | 70,000.00 |
| Jun 30, 2022 | 70,000.00 |